The US HHS Office of Inspector General is rescinding an advisory opinion concluding that a copay assistance program for Medicare beneficiaries does not raises anti-kickback concerns because it discovered the group running the program provided pharmaceutical manufacturer donors the ability to steer patients to certain drugs.
"We have determined that the public interest requires us to rescind" the opinion, OIG announced Nov. 28. The advisory opinion...







